Viewing Study NCT04480151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-05-17 @ 1:35 PM
Study NCT ID: NCT04480151
Status: COMPLETED
Last Update Posted: 2021-07-07
First Post: 2020-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)
Sponsor: University Hospital, Bordeaux
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cardiogenic Shock View
None End-stage Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cardiogenic shock View
None end stage heart failure View
None bridge to bridge View
None bridge to decision View
None left ventricular assist device View
None IMPELLA™ View
None ECLS View